Related Experiment Video
Updated: Mar 9, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1
Jing-Ru Wang1, Pei-Hua Sun1, Zhao-Xiang Ren1
1Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases, Soochow University, Suzhou, Jiangsu, China.
Glycogen synthase kinase 3 beta (GSK-3β) directly interacts with dopamine D1 receptors (D1R), modulating its function. This interaction is impaired in an animal model of schizophrenia, suggesting a novel therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Dopamine D1 receptor (D1R) dysfunction in the prefrontal cortex is linked to schizophrenia symptoms.
- Understanding D1R modulation is crucial for treating cognitive deficits and negative symptoms.
Purpose of the Study:
- To investigate the physical interaction between D1R and GSK-3β.
- To elucidate the functional modulation of D1R by GSK-3β.
Main Methods:
- Co-immunoprecipitation assays in cultured cells and brain tissues.
- Inhibition of GSK-3β using pharmacological agents.
- Assessment of D1R activation, desensitization, and endocytosis.
- Analysis in an NMDA antagonist-induced animal model of schizophrenia.
Main Results:
- D1R and GSK-3β physically interact at the C-terminal S(417)PALS(421) motif.
- GSK-3β inhibition impairs D1R activation, desensitization, and endocytosis.
- Reduced GSK-3β activity and D1R-GSK-3β association observed in a schizophrenia animal model.
Conclusions:
- GSK-3β is identified as a novel interacting protein regulating D1R function.
- A new mechanism of GSK-3β-mediated D1R regulation is revealed.
- This pathway may underlie D1R dysfunction in schizophrenia, offering potential therapeutic targets.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Neural Regulation
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

